Is Conservative Treatment Still Best for Cirrhotic Hypersplenism?
Author Information
Author(s): PAVEL G. TARAZOV, ALEXEJ A. POLYKARPOV
Primary Institution: St. Petersburg Research Institute of Roentgenology and Radiation Therapy
Hypothesis
Is conservative treatment still the best option for managing cirrhotic hypersplenism?
Conclusion
Splenic embolization is more dangerous and less effective than traditional splenectomy, but neither treatment prolongs survival compared to conservative therapy.
Supporting Evidence
- Splenectomy showed a 5% mortality rate and 10% complication rate.
- Splenic embolization had a 10% mortality rate and 19% complication rate.
- 100% improvement in hypersplenism was seen in patients who underwent splenectomy.
- Survival rates for Class A cirrhosis were 82% for splenectomy, 53% for embolization, and 81% for conservative therapy.
Takeaway
Doctors are trying to figure out the best way to treat a condition called hypersplenism in people with liver problems, and they found that one method is not better than just waiting and watching.
Methodology
Patients were divided into three treatment groups: splenectomy, splenic embolization, and conservative therapy.
Limitations
The study does not provide long-term follow-up data beyond the reported survival rates.
Participant Demographics
Patients were identical in sex, age, grade of hypersplenism, and Child-Pugh's Class of liver cirrhosis.
Want to read the original?
Access the complete publication on the publisher's website